Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026)
Regeneron Pharmaceuticals' quarterly Current Leases came in at $720.0 million in Q1 2026, little changed quarter-over-quarter from $719.7 million in Q4 2021.
Regeneron Pharmaceuticals has reported Current Leases for 8 years, with the latest figure at $720.0 million in Q1 2026.
- For the quarter ending Q1 2026, Current Leases changed N/A year-over-year to $720.0 million; the trailing twelve-month figure through Mar 2026 stood at $720.0 million (changed N/A YoY), and the FY2021 full-year result was $719.7 million, changed N/A from the prior year.
- Current Leases for Q1 2026 stood at $720.0 million, roughly flat from $719.7 million in the prior quarter.
- The five-year high for Current Leases was $720.0 million in Q1 2026, with the low at $720.0 million in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 83,991.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 720.00 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | 16.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.00 Mn |
| Dec 31, 2021 | 719.70 Mn |
| Sep 30, 2021 | 719.00 Mn |
| Jun 30, 2021 | 718.40 Mn |
| Mar 31, 2021 | 717.80 Mn |
| Dec 31, 2016 | 127.27 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.06 Mn |
| Mar 31, 2014 | 1.06 Mn |
| Dec 31, 2013 | 939,000.00 |
| Sep 30, 2013 | 794,000.00 |
| Jun 30, 2013 | 794,000.00 |
| Mar 31, 2013 | 1.47 Mn |
| Dec 31, 2012 | 1.37 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 1.18 Mn |
| Mar 31, 2012 | 1.09 Mn |
| Dec 31, 2011 | 1.01 Mn |
| Sep 30, 2011 | 920,000.00 |
| Jun 30, 2011 | 877,000.00 |
| Mar 31, 2011 | 798,000.00 |
| Dec 31, 2010 | 675,000.00 |
| Sep 30, 2010 | 634,000.00 |
| Jun 30, 2010 | 448,000.00 |